Market Cap 990.34M
Revenue (ttm) 60,000.00
Net Income (ttm) -78.26M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -130,433.34%
Debt to Equity Ratio 0.00
Volume 1,815,800
Avg Vol 2,226,006
Day's Range N/A - N/A
Shares Out 52.57M
Stochastic %K 77%
Beta 0.78
Analysts Strong Sell
Price Target $45.25

Company Profile

Avalo Therapeutics, Inc., a clinical stage biotechnology company, develops IL-1ß-based treatments for immune-mediated inflammatory diseases in the Unites States. Its lead product includes AVTX-009, a humanized monoclonal antibody that binds to interleukin-1ß, which is in phase 2 clinical trial to treat inflammatory diseases. The company was formerly known as Cerecor Inc. and changed its name to Avalo Therapeutics, Inc. in August 2021. Avalo Therapeutics, Inc. was incorporated in 2011 and is head...

Industry: Biotechnology
Sector: Healthcare
Phone: 410 522 8707
Address:
1500 Liberty Ridge Drive, Suite 321, Wayne, United States
topstockalerts
topstockalerts Jul. 3 at 10:44 PM
$AVTX feels like buyers are slowly taking control here
0 · Reply
empatheicdawg
empatheicdawg Jul. 3 at 12:04 AM
$ONDS Go check my prior posts. I called the $MOBX run i’ve called the $AVTX Run. I’m never wrong. I see something cooking and when I see it I got to say it. 5 RED CANDLES, repeat. 5 RED CANDLES doesn’t get more technical then that Bots are going to be looking at this like hmmm
0 · Reply
Trapjaw
Trapjaw Jul. 2 at 8:01 PM
$AVTX Who would have thought that at lunch oday?
0 · Reply
Trapjaw
Trapjaw Jul. 2 at 7:31 PM
0 · Reply
Trapjaw
Trapjaw Jun. 30 at 2:16 PM
0 · Reply
Trapjaw
Trapjaw Jun. 30 at 9:07 AM
$AVTX 20 + would be awesome today
0 · Reply
Trapjaw
Trapjaw Jun. 29 at 3:47 PM
$AVTX Russell kicks
0 · Reply
VincentGogh
VincentGogh Jun. 29 at 2:52 PM
$AVTX This POS has climbed its way back up.. how long before next dump 🤔
0 · Reply
Trapjaw
Trapjaw Jun. 29 at 2:11 PM
0 · Reply
Trapjaw
Trapjaw Jun. 28 at 3:21 PM
$AVTX Inclusion in the Russell 2000 and Russell 3000 indexes typically triggers short-term buying pressure and long-term liquidity . This happens because passive funds and institutional managers that track these benchmarks are required to purchase the stock .Here is what this means for the stock price:Forced Buying & Price Bump: As passive index funds adjust their portfolios to include the stock, they create high buying demand. This often leads to a noticeable price increase around the effective reconstitution date.Increased Institutional Ownership: Being in a major index validates a company's market status, attracting active fund managers who previously avoided the stock because it wasn’t benchmarked.Higher Volatility & Short Interest: Historically, index inclusion can lead to increased volatility and a rise in short interest, as professional traders utilize the stock for hedging and lending strategies.
0 · Reply
Latest News on AVTX
Avalo Therapeutics to join Russell 2000, Russell 3000

2026-06-26T11:15:39.000Z - 8 days ago

Avalo Therapeutics to join Russell 2000, Russell 3000


Avalo Therapeutics Appoints Ron Philip to Board of Directors

Jun 23, 2026, 7:00 AM EDT - 11 days ago

Avalo Therapeutics Appoints Ron Philip to Board of Directors


Avalo Therapeutics advances AVTX-010

2026-06-16T11:06:47.000Z - 18 days ago

Avalo Therapeutics advances AVTX-010


Avalo Therapeutics initiated with a Buy at BofA

2026-06-12T09:51:17.000Z - 22 days ago

Avalo Therapeutics initiated with a Buy at BofA


Avalo Therapeutics Transcript: AGM 2026

Jun 2, 2026, 8:30 AM EDT - 4 weeks ago

Avalo Therapeutics Transcript: AGM 2026


Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)

2026-05-13T13:05:49.000Z - 7 weeks ago

Avalo Therapeutics reports Q1 EPS (98c), consensus ($1.01)


Avalo Therapeutics Earnings release: Q1 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Avalo Therapeutics Earnings release: Q1 2026


Avalo Therapeutics Quarterly report: Q1 2026

May 13, 2026, 7:00 AM EDT - 7 weeks ago

Avalo Therapeutics Quarterly report: Q1 2026


Avalo Therapeutics 19.73M share Spot Secondary priced at $17.75

2026-05-07T08:32:34.000Z - 2 months ago

Avalo Therapeutics 19.73M share Spot Secondary priced at $17.75


Avalo Therapeutics price target raised to $58 from $40 at BTIG

2026-05-07T07:56:17.000Z - 2 months ago

Avalo Therapeutics price target raised to $58 from $40 at BTIG


Why Is Avalo Therapeutics Stock (AVTX) Up Today?

2026-05-06T13:03:49.000Z - 2 months ago

Why Is Avalo Therapeutics Stock (AVTX) Up Today?


Avalo Therapeutics Slides: Corporate presentation

May 5, 2026, 7:00 AM EDT - 2 months ago

Avalo Therapeutics Slides: Corporate presentation


Avalo Therapeutics Purchases Optional Milestone Buyout

Apr 28, 2026, 7:00 AM EDT - 2 months ago

Avalo Therapeutics Purchases Optional Milestone Buyout


Avalo Therapeutics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Avalo Therapeutics Proxy statement: Proxy filing


Avalo Therapeutics Proxy statement: Proxy filing

Apr 10, 2026, 8:00 AM EDT - 3 months ago

Avalo Therapeutics Proxy statement: Proxy filing


Avalo Therapeutics initiated with an Outperform at Citizens

2026-04-06T08:35:28.000Z - 3 months ago

Avalo Therapeutics initiated with an Outperform at Citizens


Avalo Therapeutics Earnings release: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Avalo Therapeutics Earnings release: Q4 2025


Avalo Therapeutics Annual report: Q4 2025

Mar 23, 2026, 7:00 AM EDT - 3 months ago

Avalo Therapeutics Annual report: Q4 2025


Avalo Therapeutics Slides: Corporate presentation

Mar 20, 2026, 7:00 AM EDT - 3 months ago

Avalo Therapeutics Slides: Corporate presentation


Avalo Therapeutics Registration statement: Registration Filing

Jan 8, 2026, 7:00 AM EST - 6 months ago

Avalo Therapeutics Registration statement: Registration Filing


Avalo Therapeutics Slides: Investor Presentation

Nov 30, 2025, 6:00 PM EST - 7 months ago

Avalo Therapeutics Slides: Investor Presentation


Avalo Therapeutics Transcript: Stifel 2025 Healthcare Conference

Nov 12, 2025, 2:40 PM EST - 8 months ago

Avalo Therapeutics Transcript: Stifel 2025 Healthcare Conference


Avalo Therapeutics Earnings release: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Avalo Therapeutics Earnings release: Q3 2025


Avalo Therapeutics Quarterly report: Q3 2025

Nov 6, 2025, 7:00 AM EST - 8 months ago

Avalo Therapeutics Quarterly report: Q3 2025


Avalo Therapeutics Slides: Corporate Presentation

Nov 3, 2025, 6:00 PM EST - 8 months ago

Avalo Therapeutics Slides: Corporate Presentation


Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors

Sep 22, 2025, 7:00 AM EDT - 10 months ago

Avalo Therapeutics Appoints Kevin R. Lind to Board of Directors


Avalo Therapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Avalo Therapeutics Quarterly report: Q2 2025


Avalo Therapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:00 PM EDT - 11 months ago

Avalo Therapeutics Earnings release: Q2 2025


Avalo Therapeutics Slides: Corporate Presentation

Jun 19, 2025, 2:00 AM EDT - 1 year ago

Avalo Therapeutics Slides: Corporate Presentation


Avalo Therapeutics Earnings release: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

Avalo Therapeutics Earnings release: Q1 2025


Avalo Therapeutics Quarterly report: Q1 2025

May 12, 2025, 7:00 AM EDT - 1 year ago

Avalo Therapeutics Quarterly report: Q1 2025


Avalo Therapeutics Proxy statement: Proxy Filing

May 1, 2025, 8:00 AM EDT - 1 year ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Proxy statement: Proxy Filing

May 1, 2025, 8:00 AM EDT - 1 year ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Earnings release: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Avalo Therapeutics Earnings release: Q4 2024


Avalo Therapeutics Annual report: Q4 2024

Mar 19, 2025, 7:00 PM EDT - 1 year ago

Avalo Therapeutics Annual report: Q4 2024


Avalo Therapeutics Slides: Corporate Presentation

Jan 11, 2025, 7:00 AM EST - 1 year ago

Avalo Therapeutics Slides: Corporate Presentation


Avalo Therapeutics Quarterly report: Q3 2024

Nov 6, 2024, 6:00 PM EST - 1 year ago

Avalo Therapeutics Quarterly report: Q3 2024


Avalo Therapeutics Slides: Corporate Presentation

Sep 9, 2024, 7:00 AM EDT - 1 year ago

Avalo Therapeutics Slides: Corporate Presentation


Avalo Therapeutics Earnings release: Q2 2024

Aug 11, 2024, 6:00 PM EDT - 2 years ago

Avalo Therapeutics Earnings release: Q2 2024


Avalo Therapeutics Quarterly report: Q2 2024

Aug 11, 2024, 6:00 PM EDT - 2 years ago

Avalo Therapeutics Quarterly report: Q2 2024


Avalo Therapeutics Registration statement: Registration Filing

Jul 29, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Registration statement: Registration Filing


Avalo Therapeutics Registration statement: Registration Filing

Jul 11, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Registration statement: Registration Filing


Avalo Therapeutics Proxy statement: Proxy Filing

Jun 27, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Proxy statement: Proxy Filing

Jun 27, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Proxy statement: Proxy Filing

Jun 7, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Earnings release: Q1 2024

May 12, 2024, 6:00 PM EDT - 2 years ago

Avalo Therapeutics Earnings release: Q1 2024


Avalo Therapeutics Quarterly report: Q1 2024

May 12, 2024, 6:00 PM EDT - 2 years ago

Avalo Therapeutics Quarterly report: Q1 2024


Avalo Therapeutics Annual report: Q4 2023

Mar 28, 2024, 7:00 PM EDT - 2 years ago

Avalo Therapeutics Annual report: Q4 2023


Avalo Therapeutics Proxy statement: Proxy Filing

Mar 28, 2024, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Announces 1-for-240 Reverse Stock Split

Dec 27, 2023, 7:00 AM EST - 2 years ago

Avalo Therapeutics Announces 1-for-240 Reverse Stock Split


Avalo Therapeutics Proxy statement: Proxy Filing

Dec 7, 2023, 7:00 AM EST - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Earnings release: Q3 2023

Nov 8, 2023, 6:00 PM EST - 2 years ago

Avalo Therapeutics Earnings release: Q3 2023


Avalo Therapeutics Quarterly report: Q3 2023

Nov 8, 2023, 6:00 PM EST - 2 years ago

Avalo Therapeutics Quarterly report: Q3 2023


Avalo Completes Divestiture of AVTX-800 Series

Oct 31, 2023, 7:00 AM EDT - 2 years ago

Avalo Completes Divestiture of AVTX-800 Series


Avalo Therapeutics Proxy statement: Proxy Filing

Oct 19, 2023, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Therapeutics Proxy statement: Proxy Filing

Oct 19, 2023, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

Oct 12, 2023, 11:26 AM EDT - 2 years ago

Top trending biotech stocks: ANVS, MTNB, AVTX, TPST

ANVS MTNB TPST


Avalo Therapeutics Proxy statement: Proxy Filing

Oct 5, 2023, 8:00 AM EDT - 2 years ago

Avalo Therapeutics Proxy statement: Proxy Filing


Avalo Enters into Agreement to Divest AVTX-800 Series

Sep 12, 2023, 7:00 AM EDT - 3 years ago

Avalo Enters into Agreement to Divest AVTX-800 Series


Avalo Therapeutics Earnings release: Q2 2023

Aug 2, 2023, 6:00 PM EDT - 3 years ago

Avalo Therapeutics Earnings release: Q2 2023


Avalo Therapeutics Quarterly report: Q2 2023

Aug 2, 2023, 6:00 PM EDT - 3 years ago

Avalo Therapeutics Quarterly report: Q2 2023


Avalo to Participate in SVB Securities Therapeutics Forum

Jul 6, 2023, 4:01 PM EDT - 3 years ago

Avalo to Participate in SVB Securities Therapeutics Forum


Avalo to Present at the Jefferies Healthcare Conference

Jun 1, 2023, 7:00 AM EDT - 3 years ago

Avalo to Present at the Jefferies Healthcare Conference


topstockalerts
topstockalerts Jul. 3 at 10:44 PM
$AVTX feels like buyers are slowly taking control here
0 · Reply
empatheicdawg
empatheicdawg Jul. 3 at 12:04 AM
$ONDS Go check my prior posts. I called the $MOBX run i’ve called the $AVTX Run. I’m never wrong. I see something cooking and when I see it I got to say it. 5 RED CANDLES, repeat. 5 RED CANDLES doesn’t get more technical then that Bots are going to be looking at this like hmmm
0 · Reply
Trapjaw
Trapjaw Jul. 2 at 8:01 PM
$AVTX Who would have thought that at lunch oday?
0 · Reply
Trapjaw
Trapjaw Jul. 2 at 7:31 PM
0 · Reply
Trapjaw
Trapjaw Jun. 30 at 2:16 PM
0 · Reply
Trapjaw
Trapjaw Jun. 30 at 9:07 AM
$AVTX 20 + would be awesome today
0 · Reply
Trapjaw
Trapjaw Jun. 29 at 3:47 PM
$AVTX Russell kicks
0 · Reply
VincentGogh
VincentGogh Jun. 29 at 2:52 PM
$AVTX This POS has climbed its way back up.. how long before next dump 🤔
0 · Reply
Trapjaw
Trapjaw Jun. 29 at 2:11 PM
0 · Reply
Trapjaw
Trapjaw Jun. 28 at 3:21 PM
$AVTX Inclusion in the Russell 2000 and Russell 3000 indexes typically triggers short-term buying pressure and long-term liquidity . This happens because passive funds and institutional managers that track these benchmarks are required to purchase the stock .Here is what this means for the stock price:Forced Buying & Price Bump: As passive index funds adjust their portfolios to include the stock, they create high buying demand. This often leads to a noticeable price increase around the effective reconstitution date.Increased Institutional Ownership: Being in a major index validates a company's market status, attracting active fund managers who previously avoided the stock because it wasn’t benchmarked.Higher Volatility & Short Interest: Historically, index inclusion can lead to increased volatility and a rise in short interest, as professional traders utilize the stock for hedging and lending strategies.
0 · Reply
Trapjaw
Trapjaw Jun. 26 at 8:51 PM
$AVTX 1.8 m AH vol. & no movement🤣
0 · Reply
Trapjaw
Trapjaw Jun. 26 at 8:15 PM
$AVTX massive vol. ast minutes
0 · Reply
Trapjaw
Trapjaw Jun. 26 at 8:01 PM
$AVTX nice
0 · Reply
Trapjaw
Trapjaw Jun. 26 at 1:15 PM
$AVTX https://www.gurufocus.com/news/8934103/avalo-therapeutics-avtx-joins-russell-2000-and-3000-indices
0 · Reply
Trapjaw
Trapjaw Jun. 26 at 1:13 PM
$AVTX https://www.stocktitan.net/news/AVTX/avalo-therapeutics-to-join-the-russell-2000-and-russell-3000-ovi8lmcgfcv9.html
0 · Reply
focafoca99
focafoca99 Jun. 26 at 11:50 AM
$AVTX added to the Russell 2000 and Russell 3000 indexes, effective after market close on June 26.
0 · Reply
k3vl4r
k3vl4r Jun. 25 at 3:12 PM
$AVTX +10% since the institutional ownership jumped. It was a signal!
0 · Reply
Trapjaw
Trapjaw Jun. 25 at 2:27 PM
0 · Reply
Trapjaw
Trapjaw Jun. 25 at 2:21 PM
0 · Reply
Trapjaw
Trapjaw Jun. 24 at 3:54 PM
0 · Reply
Trapjaw
Trapjaw Jun. 24 at 10:33 AM
$AVTX today over 20 ?
0 · Reply
Trapjaw
Trapjaw Jun. 23 at 8:37 PM
0 · Reply